European Commission Approves Enhanced Wegovy Ob...

By João L. Carapinha

February 18, 2026

European Commission Backs Wegovy Obesity Treatment with 7.2 mg Dose The European Commission has approved a higher 7.2 mg maintenance dose of
Genotype ECG Prediction
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
KEYTRUDA Ovarian Cancer Treatments: FDA Approves New Regimens for Platinum-Re...
National HealthTech Access: Transforming NHS Adoption and Equity
Datroway Metastatic Breast Cancer: FDA Grants Priority Review for Breakthroug...
FDA Confirms GLP-1 RA Safety Review: No Increased Suicidal Risk
CHMP January 2026 Approvals: Expanding Access to Innovative Therapies
Accelerating FAST-EU Clinical Trials
Alzheimer’s Care Innovation: Advancing Implementation Across Europe
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...